Skip to content

A Novel Mobile Application for Heart Failure Assessment and Management.

A Novel Mobile Application for an Integrated Approach to Cardiac Failure Assessment and Management - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082346
Enrollment
50
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I501- Left ventricular failure, unspecified

Interventions

Intervention1: A Novel Mobile Application for Cardiac Failure patients: A Novel Mobile Application for Integrated Cardiac Failure Assessment and Management as compared with a Conventional method of fo

Sponsors

Saveetha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed with heart failure by a qualified healthcare professional and regularly visiting the hospital clinic for medical follow-ups. 2. Between 20 to 75 years of age. 3. Able to use a smartphone app. 4. Able to perform regular physical activity according to the patients self-identification and the judgment of their primary cardiologist 5. Willingness to provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Age: Participants under the age of 20 years. 2. Patients with severe cognitive impairment or inability to comprehend and use the mobile application effectively. 3. Patients with a terminal illness or life expectancy of less than six months. 4. Patients currently enrolled in other clinical trials or research studies related to cardiac failure management. 5. Patients with recent major cardiovascular events or surgeries within the past three months

Design outcomes

Primary

MeasureTime frame
Improved symptom management, enhanced medication adherence, increased patient engagement, and better communication with healthcare providersTimepoint: At baseline and three months

Secondary

MeasureTime frame
1. Reduced complications 2. Reduced hospitalizations 3. Improved quality of life.Timepoint: At baseline and three months

Countries

India

Contacts

Public ContactDR KANNAN

Saveetha Medical College and Hospital

endork@yahoo.com9710071284

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026